[Clinical and biological characteristics and prognosis of patients with biclonal multiple myeloma]

Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):677-679. doi: 10.3760/cma.j.issn.0253-2727.2021.08.011.

[Article in Chinese]

Authors

W Cheng¹, Y L Li¹, Z F Huang¹, Z B Li¹, X Y Dong¹, B J Shang¹, L Zhang¹, J Shi¹, Z M Zhu¹

Affiliation

¹ Department of Hematology, Zhengzhou University People's Hospital, Institute of Hematology, Henan Province People's Hospital, Henan Key Laboratory of Stem Cell Regulation and Differentiation, Zhengzhou 450003, China.

PMID: 34547875
PMCID: PMC8501275
DOI: 10.3760/cma.j.issn.0253-2727.2021.08.011

No abstract available

MeSH terms

Humans
Multiple Myeloma*
Prognosis

Grants and funding

基金项目：河南省医学科技攻关计划项目（SB20191094）